Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)

SHE:003017 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	442.83	353.99	382.37	131.11	131.88	69.36
Trading Asset Securities	-	40.45	-	296.48	279.77	370.08
Cash & Short-Term Investments	442.83	394.44	382.37	427.59	411.65	439.44
Cash Growth	17.21%	3.16%	-10.58%	3.87%	-6.33%	727.27%
Accounts Receivable	140.26	127.05	103.94	138.96	134.24	147.57
Other Receivables	1.13	5.77	6.59	9.45	18.65	16.57
Receivables	141.39	132.82	110.54	148.41	152.89	164.14
Inventory	115.83	119.78	152.23	126.87	161.61	69.84
Prepaid Expenses	-	0.31	0.32	0.35	0.25	0.25
Other Current Assets	42.77	43.2	16.18	24.94	16.3	24.62
Total Current Assets	742.82	690.55	661.63	728.16	742.7	698.29
Property, Plant & Equipment	739.39	681.46	671.49	616.17	528.02	433.57
Long-Term Investments	123.03	121.39	54.84	2.5	2.52	1.91
Other Intangible Assets	89.02	91.06	93.35	95.36	56.73	57.48
Long-Term Deferred Tax Assets	30.93	32.31	44.17	45.46	5.54	4.12
Long-Term Deferred Charges	1.94	2.1	-	0.05	0.1	0.15
Other Long-Term Assets	25.66	34.67	21.18	20.36	38.73	33.28
Total Assets	1,753	1,654	1,547	1,508	1,374	1,229
Accounts Payable	184.06	158.91	189.42	125.77	149.16	168.48
Accrued Expenses	18.27	22.38	21.58	28.75	11.35	9.07
Short-Term Debt	331.13	358.06	180.43	252.11	139.07	-
Current Portion of Long-Term Debt	-	9.51	-	30.03	-	-
Current Portion of Leases	-	-	0.87	-	-	-
Current Income Taxes Payable	10.52	0	0.07	-	0.15	1.82
Current Unearned Revenue	6.03	3.69	5.78	8.03	7.91	11.92
Other Current Liabilities	55.99	15.16	32.1	33.54	9.53	9.22
Total Current Liabilities	606	567.7	430.26	478.24	317.16	200.51
Long-Term Debt	13.51	-	69.06	-	39.8	49.87
Long-Term Leases	2.03	-	-	-	0.87	-
Long-Term Unearned Revenue	7.85	9.01	11.35	11.96	9.6	11.25
Long-Term Deferred Tax Liabilities	21.42	23.69	27.79	32.81	16.21	9.04
Total Liabilities	650.82	600.4	538.47	523.01	383.64	270.67
Common Stock	84	84	84	60	60	60
Additional Paid-In Capital	545.36	528.23	519.47	537.19	563.99	563.99
Retained Earnings	482.11	455.2	428.13	413.12	366.71	332.7
Treasury Stock	-18.32	-17.93	-25.42	-25.42	-	-
Comprehensive Income & Other	4.33	2.66	2.02	0.16	0.01	1.44
Total Common Equity	1,097	1,052	1,008	985.05	990.71	958.13
Minority Interest	4.51	0.99	-	-	-	-
Shareholders' Equity	1,102	1,053	1,008	985.05	990.71	958.13
Total Liabilities & Equity	1,753	1,654	1,547	1,508	1,374	1,229
Total Debt	346.67	367.56	250.37	282.14	179.74	49.87
Net Cash (Debt)	96.16	26.87	132	145.45	231.91	389.57
Net Cash Growth	147.77%	-79.64%	-9.25%	-37.28%	-40.47%	1193.42%
Net Cash Per Share	1.19	0.33	1.63	1.78	2.76	5.86
Filing Date Shares Outstanding	81.26	83.01	81.75	80.08	84	84
Total Common Shares Outstanding	81.26	83.23	81.2	80.08	84	84
Working Capital	136.82	122.85	231.38	249.92	425.53	497.78
Book Value Per Share	13.51	12.64	12.42	12.30	11.79	11.41
Tangible Book Value	1,008	961.1	914.85	889.69	933.98	900.65
Tangible Book Value Per Share	12.41	11.55	11.27	11.11	11.12	10.72
Buildings	-	338.1	271.87	270.86	218.74	190.3
Machinery	-	574.75	544.06	569.59	451.65	298.26
Construction In Progress	-	155.15	180.84	52.15	84.75	135.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.